Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog

Oncology Today with Dr Neil Love

English - December 21, 2022 14:00 - 49 minutes - 45.8 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Novel Immunotherapeutic Strategies in Melanoma with Dr Omid Hamid

Next Episode: Managing Metastatic Urothelial Bladder Cancer with Dr Scott Tagawa

Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayOvarianPARP22).

Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer.

CME information and select publications here.